SCHEMBL1375728

SCHEMBL1375728

CC(C)OCCC(=O)N(C)C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.45
CHRNA4 P43681 5/20 0.45
CHRNB4 P30926 3/20 0.45
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.32
PKM P14618 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CHRNA3 P32297 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
EPHX2 P34913 1/20 0.30
TSHR P16473 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16467044 0.83 TP53 (0.33) CHRNB2CHRNA4CHRNB4ALDH1A1TP53
SCHEMBL1374563 0.81 ALDH1A1 (0.33) ALDH1A1TP53PKM
SCHEMBL14227390 0.81 FAAH (0.33) ALDH1A1TP53PKM
SCHEMBL1374337 0.81 ALDH1A1 (0.43) CHRNB2CHRNA4CHRNB4ALDH1A1
SCHEMBL1374476 0.80 ALDH1A1 (0.35) ALDH1A1TP53PKMKDM4EEPHX2
SCHEMBL25089679 0.79 MEN1 (0.34) ALDH1A1KDM4EL3MBTL1
SCHEMBL1377034 0.78 LMNA (0.52) ALDH1A1HSD17B10TSHRL3MBTL1
SCHEMBL14227393 0.78 TSHR (0.32) ALDH1A1TSHR
SCHEMBL1376712 0.78 EPHX2 (0.33) CHRNB2CHRNA4CHRNB4ALDH1A1KDM4E
SCHEMBL21554075 0.78 CHRNB2 (0.43) CHRNB2CHRNA4CHRNB4ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637804-B2 Ink jet recording method SEIKO EPSON CORPORATION (JP) 2026-05-26 US disclosed
US-12637578-B2 Ink jet ink composition and recording method SEIKO EPSON CORPORATION (JP) 2026-05-26 US disclosed
US-12630728-B2 Ink set and recording method SEIKO EPSON CORPORATION (JP) 2026-05-19 US disclosed
US-12629934-B2 Recording method and recording device SEIKO EPSON CORPORATION (JP) 2026-05-19 US disclosed
US-12630973-B2 Recording method SEIKO EPSON CORPORATION (JP) 2026-05-19 US disclosed
US-12624242-B2 Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method SEIKO EPSON CORPORATION (JP) 2026-05-12 US disclosed
US-20260125850-A1 Pretreatment Liquid For Textile Printing And Textile Printing Method SEIKO EPSON CORP (JP) 2026-05-07 US disclosed
US-20260116073-A1 Maintenance Method And Recording Apparatus SEIKO EPSON CORP (JP) 2026-04-30 US disclosed
US-20260109872-A1 Ink Jet Ink Composition And Ink Jet Recording Method SEIKO EPSON CORP (JP) 2026-04-23 US disclosed
US-12584030-B2 Ink jet ink composition and recording method SEIKO EPSON CORPORATION (JP) 2026-03-24 US disclosed
EP-2837619-A1 METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE Idemitsu Kosan Co., Ltd (JP) 2015-02-18 EP disclosed
EP-2824150-A1 Inkjet ink set and image forming method FUJIFILM Corporation (JP) 2015-01-14 EP disclosed
EP-2703466-A1 WATER-REPELLENT AND OIL-REPELLENT AGENT COMPOUND, MANUFACTURING METHOD THEREFOR, AND ARTICLE Asahi Glass Company, Limited (JP) 2014-03-05 EP disclosed
EP-2703465-A1 WATER-REPELLING, OIL-REPELLING AGENT COMPOSITION, METHOD FOR PRODUCING SAME, AND ARTICLE Asahi Glass Company, Limited (JP) 2014-03-05 EP disclosed
US-20140051797-A1 WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE ASAHI GLASS COMPANY, LIMITED (JP) 2014-02-20 US disclosed
US-20140045992-A1 WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE ASAHI GLASS COMPANY, LIMITED (JP) 2014-02-13 US disclosed
US-8563495-B2 Resist remover composition and method for removing resist using same IDEMITSU KOSAN CO., LTD. (JP) 2013-10-22 US disclosed
US-20130071415-A1 Heterocyclic Compounds as Janus Kinase Inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2013-03-21 US disclosed
EP-2568019-A1 Inkjet ink JNC Corporation (JP) 2013-03-13 EP disclosed
US-20110287995-A1 RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125850-A1 Pretreatment Liquid For Textile Printing And Textile Printing Method ADH1A, RARA, RBP4 CHRNB2 3483/4885CHRNA4 929/4885CHRNB4 1826/4885
US-12624242-B2 Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method HAO2, PHOSPHO1, HAO1 CHRNB2 1355/4885CHRNA4 3019/4885CHRNB4 1825/4885
US-20260109872-A1 Ink Jet Ink Composition And Ink Jet Recording Method COPE, EED, VCL CHRNB2 2920/4885CHRNA4 2491/4885CHRNB4 2841/4885
US-12637578-B2 Ink jet ink composition and recording method TYR, RB1, WNT1 CHRNB2 2298/4885CHRNA4 3919/4885CHRNB4 3648/4885
US-12630973-B2 Recording method DOT1L, EMD, EZH2 CHRNB2 1161/4885CHRNA4 1349/4885CHRNB4 1753/4885
US-20260116073-A1 Maintenance Method And Recording Apparatus WFS1, HCN2, SMN1; SMN2 CHRNB2 547/4885CHRNA4 498/4885CHRNB4 815/4885
US-12629934-B2 Recording method and recording device HCN2, MC1R, TYR CHRNB2 68/4885CHRNA4 408/4885CHRNB4 218/4885
US-20130071415-A1 Heterocyclic Compounds as Janus Kinase Inhibitors JAK2, JAK1, JAK3 CHRNB2 4883/4885CHRNA4 4878/4885CHRNB4 4884/4885
US-12630728-B2 Ink set and recording method DOT1L, SET, ALKBH3 CHRNB2 1092/4885CHRNA4 1273/4885CHRNB4 1602/4885
US-12637804-B2 Ink jet recording method IK, PRPH, SLC6A19 CHRNB2 1280/4885CHRNA4 1489/4885CHRNB4 1574/4885
US-12584030-B2 Ink jet ink composition and recording method LSM8, SMURF1, SMAD3 CHRNB2 2421/4885CHRNA4 2947/4885CHRNB4 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.